(Q43040681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

M Tevfik Dorak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Gbolahan O Folayan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Santosh Niwas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Dirk J van Leeuwen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Leland J Yee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Richard A Kaslow

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

167-175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1385/ir:26:1-3:167

14 December 2019

exact match

0 references

cites work

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

1 reference

12 December 2020

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

12 December 2020

Host genetic factors influence disease progression in chronic hepatitis C.

1 reference

12 December 2020

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

12 December 2020

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

1 reference

12 December 2020

Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression

1 reference

12 December 2020

Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus

1 reference

12 December 2020

Host genetic factors influencing the outcome of hepatitis

1 reference

12 December 2020

Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.

1 reference

12 December 2020

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

12 December 2020

Host-pathogen interactions in emerging and re-emerging infectious diseases: a genomic perspective of tuberculosis, malaria, human immunodeficiency virus infection, hepatitis B, and cholera

1 reference

12 December 2020

Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance

1 reference

12 December 2020

The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe.

1 reference

12 December 2020

Chemokines in immunity

1 reference

12 December 2020

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection

1 reference

12 December 2020

Clinical significance of hepatitis C virus genotypes

1 reference

12 December 2020

Hepatitis C virus infection

1 reference

12 December 2020

Genetics of susceptibility to human infectious disease

1 reference

12 December 2020

Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus

1 reference

12 December 2020

Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance

1 reference

12 December 2020

Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection

1 reference

12 December 2020

Chronic viral hepatitis and the human genome

1 reference

12 December 2020

Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression

1 reference

12 December 2020

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

1 reference

12 December 2020

Genetic determinants of HIV-1 infection and its manifestations.

1 reference

12 December 2020

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

12 December 2020

Genetic susceptibility in chronic viral hepatitis

1 reference

12 December 2020

Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up

1 reference

12 December 2020

Class II HLA alleles and hepatitis B virus persistence in African Americans

1 reference

12 December 2020

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

1 reference

12 December 2020

Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders

1 reference

12 December 2020

Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes

1 reference

12 December 2020

Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function

1 reference

12 December 2020

Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:26:1-3:167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12403355%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

14 December 2019

0 references

1 reference